Article
Structure and Activities of the NS1 Influenza Protein and Progress in the Development of Small-Molecule Drugs
19 Apr 2021
Abstract excerpt
The influenza virus causes human disease on a global scale and significant morbidity and mortality. The existing vaccination regime remains vulnerable to antigenic drift, and more seriously, a small number of viral mutations could lead to drug resistance. Therefore, the development of a new additional therapeutic small molecule-based anti-influenza virus is urgently required. The NS1 influenza gene plays a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
